Evidence map›Paper›PMID 35989704›Full record

ArticleBiology methods & protocols2022

Combining CRISPR-Cas12a with terminal deoxynucleotidyl transferase dependent reporter elongation for pathogen detection using lateral flow test strips.

Nicole F Berghuis, Roos Mars-Groenendijk, Ruud W Busker, Armand Paauw, Hans C van Leeuwen

Abstract read
In one paragraph

Article in Biology methods & protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicole F BerghuisDepartment of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, 2288 GJ Rijswijk, The Netherlands.ORCID https://orcid.org/0000-0001-8204-3941
Roos Mars-GroenendijkDepartment of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, 2288 GJ Rijswijk, The Netherlands.
Ruud W BuskerDepartment of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, 2288 GJ Rijswijk, The Netherlands.
Armand PaauwDepartment of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, 2288 GJ Rijswijk, The Netherlands.
Hans C van LeeuwenDepartment of CBRN Protection, Netherlands Organization for Applied Scientific Research TNO, 2288 GJ Rijswijk, The Netherlands.ORCID https://orcid.org/0000-0003-1694-8421

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR-Cas (CC)-based detection technologies have some exceptional features, which hold the promise of developing into the next-generation diagnostic platforms. One of these features is the ability to trigger non-specific single-stranded DNA/RNA cleavage activity after specific target recognition and Cas enzyme activation. This cleavage activity can be visualized either by single-stranded DNA/RNA fluorescence resonance energy transfer quenching reporters or via lateral flow strips, which separate and detect the cleaved reporters. In a previous study, we reported coupling CC-cleavage activity with the enzyme terminal deoxynucleotidyl transferase (TdT) that elongates cleaved ssDNA reporter fragments with dTTP nucleotides. These elongated poly(thymine) tails then act as scaffolds for the formation of copper nanoparticles which generate a bright fluorescent signal upon UV excitation. In the current study, we visualize the poly(thymine) tails on lateral flow strips, using different combinations of biotinylated or fluorescein-labeled nucleotides, various reporters, and capture oligos. One particular approach, using a fluorescein reporter, reached a target sensitivity of <1 pM and was named Cas activity assay on a strip and was tested using

Indexed as

CRISPR–CASDNA detectionFRETlateral flow assaypathogenpoint of care

Identifiers

PMID35989704
PMCPMC9384837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.